Handling Protein Flexibility in Docking and High‐Throughput Docking: From Algorithms to Applications

[1]  Charles L. Brooks,et al.  Detailed analysis of grid‐based molecular docking: A case study of CDOCKER—A CHARMm‐based MD docking algorithm , 2003, J. Comput. Chem..

[2]  Sai Chetan K. Sukuru,et al.  Discovering New Classes of Brugia malayi Asparaginyl-tRNA Synthetase Inhibitors and Relating Specificity to Conformational Change , 2006, J. Comput. Aided Mol. Des..

[3]  Christopher R. Corbeil,et al.  Docking Ligands into Flexible and Solvated Macromolecules. 3. Impact of Input Ligand Conformation, Protein Flexibility, and Water Molecules on the Accuracy of Docking Programs , 2009, J. Chem. Inf. Model..

[4]  Heather A Carlson,et al.  Small molecule inhibitors of the MDM2-p53 interaction discovered by ensemble-based receptor models. , 2007, Journal of the American Chemical Society.

[5]  Sharangdhar S. Phatak,et al.  6-Methoxy-N-alkyl isatin acylhydrazone derivatives as a novel series of potent selective cannabinoid receptor 2 inverse agonists: design, synthesis, and binding mode prediction. , 2009, Journal of medicinal chemistry.

[6]  D. Koshland.  The Key–Lock Theory and the Induced Fit Theory , 1995 .

[7]  Gennady M Verkhivker,et al.  Computer simulations of ligand–protein binding with ensembles of protein conformations: A Monte Carlo study of HIV‐1 protease binding energy landscapes , 1999 .

[8]  Rafael Najmanovich,et al.  Side‐chain flexibility in proteins upon ligand binding , 2000, Proteins.

[9]  M. Entzeroth,et al.  Emerging trends in high-throughput screening. , 2003, Current opinion in pharmacology.

[10]  Claudio N. Cavasotto,et al.  Homology modeling in drug discovery: current trends and applications. , 2009, Drug discovery today.

[11]  J. Mccammon,et al.  Computational drug design accommodating receptor flexibility: the relaxed complex scheme. , 2002, Journal of the American Chemical Society.

[12]  Noeris K. Salam,et al.  Novel PPAR‐gamma Agonists Identified from a Natural Product Library: A Virtual Screening, Induced‐Fit Docking and Biological Assay Study , 2007, Chemical biology & drug design.

[13]  Christopher W. Murray,et al.  The sensitivity of the results of molecular docking to induced fit effects: Application to thrombin, thermolysin and neuraminidase , 1999, J. Comput. Aided Mol. Des..

[14]  J. Sussman,et al.  Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs. , 1999, Structure.

[15]  Claudio N. Cavasotto,et al.  Structure-based development of target-specific compound libraries. , 2006, Drug discovery today.

[16]  William Seibel,et al.  Theoretical and practical considerations in virtual screening: a beaten field? , 2008, Current medicinal chemistry.

[17]  J J Baldwin,et al.  Positions of His‐64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitors , 1994, Protein science : a publication of the Protein Society.

[18]  Anirban Mahapatra.  Screening for success. , 2008, ACS chemical biology.

[19]  R. Glen,et al.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.

[20]  J. Bajorath,et al.  Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.

[21]  Dan S. Tawfik,et al.  Antibody Multispecificity Mediated by Conformational Diversity , 2003, Science.

[22]  Vincent Breton,et al.  Design and Discovery of Plasmepsin II Inhibitors Using an Automated Workflow on Large‐Scale Grids , 2009, ChemMedChem.

[23]  Richard A. Lewis,et al.  Lessons in molecular recognition: the effects of ligand and protein flexibility on molecular docking accuracy. , 2004, Journal of medicinal chemistry.

[24]  M. V. Regenmortel,et al.  Molecular recognition in the post-reductionist era. , 1999 .

[25]  Claudio N. Cavasotto,et al.  2,3‐Dihydro‐1‐Benzofuran Derivatives as a Series of Potent Selective Cannabinoid Receptor 2 Agonists: Design, Synthesis, and Binding Mode Prediction through Ligand‐Steered Modeling , 2009, ChemMedChem.

[26]  R. Nussinov,et al.  Folding funnels, binding funnels, and protein function , 1999, Protein science : a publication of the Protein Society.

[27]  J. Andrew McCammon,et al.  Discovery of drug-like inhibitors of an essential RNA-editing ligase in Trypanosoma brucei , 2008, Proceedings of the National Academy of Sciences.

[28]  Claudio N. Cavasotto and Narender Singh.  Docking and High Throughput Docking: Successes and the Challenge of Protein Flexibility , 2008 .

[29]  Olivier Sperandio,et al.  Receptor-based computational screening of compound databases: the main docking-scoring engines. , 2006, Current protein & peptide science.

[30]  Leslie A Kuhn,et al.  Modeling correlated main‐chain motions in proteins for flexible molecular recognition , 2004, Proteins.

[31]  Claudio N. Cavasotto,et al.  Representing receptor flexibility in ligand docking through relevant normal modes. , 2005, Journal of the American Chemical Society.

[32]  D. Koshland.  Application of a Theory of Enzyme Specificity to Protein Synthesis. , 1958, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Kidera,et al.  Protein structural change upon ligand binding: linear response theory. , 2005, Physical review letters.

[34]  Claudio N. Cavasotto,et al.  Protein flexibility in ligand docking and virtual screening to protein kinases. , 2004, Journal of molecular biology.

[35]  Matthew P. Repasky,et al.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.

[36]  Claudio N. Cavasotto,et al.  High-throughput and in silico screenings in drug discovery , 2009, Expert opinion on drug discovery.

[37]  X. Barril,et al.  Unveiling the full potential of flexible receptor docking using multiple crystallographic structures. , 2005, Journal of medicinal chemistry.

[38]  Claudio N. Cavasotto,et al.  Ligand docking and structure-based virtual screening in drug discovery. , 2007, Current topics in medicinal chemistry.

[39]  Woody Sherman,et al.  Use of an Induced Fit Receptor Structure in Virtual Screening , 2006, Chemical biology & drug design.

[40]  K. Lundstrom,et al.  Structural genomics and drug discovery , 2007, Journal of cellular and molecular medicine.

[41]  Jung-Hsin Lin,et al.  The relaxed complex method: Accommodating receptor flexibility for drug design with an improved scoring scheme. , 2003, Biopolymers.

[42]  Frits Daeyaert,et al.  A pharmacophore docking algorithm and its application to the cross‐docking of 18 HIV‐NNRTI's in their binding pockets , 2004, Proteins.

[43]  R. Nussinov,et al.  Folding funnels and binding mechanisms. , 1999, Protein engineering.

[44]  J M Blaney,et al.  A geometric approach to macromolecule-ligand interactions. , 1982, Journal of molecular biology.

[45]  J. Tainer,et al.  Screening a peptidyl database for potential ligands to proteins with side‐chain flexibility , 1998, Proteins.

[46]  I. Kuntz,et al.  Automated docking with grid‐based energy evaluation , 1992 .

[47]  J. Andrew McCammon,et al.  Method for Including the Dynamic Fluctuations of a Protein in Computer-Aided Drug Design , 1999 .

[48]  Yuan-Ping Pang,et al.  Potent New Small-Molecule Inhibitor of Botulinum Neurotoxin Serotype A Endopeptidase Developed by Synthesis-Based Computer-Aided Molecular Design , 2009, PloS one.

[49]  G. Degliesposti,et al.  Binding Estimation after Refinement, a New Automated Procedure for the Refinement and Rescoring of Docked Ligands in Virtual Screening , 2009, Chemical biology & drug design.

[50]  Brian K Shoichet,et al.  Testing a flexible-receptor docking algorithm in a model binding site. , 2004, Journal of molecular biology.

[51]  I. Kuntz,et al.  Molecular docking to ensembles of protein structures. , 1997, Journal of molecular biology.

[52]  L. Kuhn,et al.  Virtual screening with solvation and ligand-induced complementarity , 2000 .

[53]  Raymond C Stevens,et al.  Long live structural biology , 2004, Nature Structural &Molecular Biology.

[54]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.

[55]  R. Friesner,et al.  Novel procedure for modeling ligand/receptor induced fit effects. , 2006, Journal of medicinal chemistry.

[56]  Xingzhou Li,et al.  Synthesis and biological evaluation of 1,2,4-trisubstituted imidazoles and 1,3,5-trisubstituted pyrazoles as inhibitors of transforming growth factor beta type 1 receptor (ALK5). , 2009, Bioorganic & medicinal chemistry letters.

[57]  Johannes H. Voigt,et al.  Cross-Docking of Inhibitors into CDK2 Structures. 1 , 2008, J. Chem. Inf. Model..

[58]  E. Fischer.  Einfluss der Configuration auf die Wirkung der Enzyme , 1894 .

[59]  L. Tong,et al.  Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site , 2002, Nature Structural Biology.

[60]  Claudio N. Cavasotto,et al.  Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening. , 2008, Journal of medicinal chemistry.

[61]  B. Schweitzer,et al.  Dihydrofolate reductase as a therapeutic target , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[62]  P. Goodford.  A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.

[63]  Holger Gohlke,et al.  The Amber biomolecular simulation programs , 2005, J. Comput. Chem..

[64]  Dora M Schnur.  Recent trends in library design: 'rational design' revisited. , 2008, Current opinion in drug discovery & development.

[65]  G. Klebe,et al.  Successful virtual screening for a submicromolar antagonist of the neurokinin-1 receptor based on a ligand-supported homology model. , 2004, Journal of medicinal chemistry.

[66]  B. Shoichet,et al.  Soft docking and multiple receptor conformations in virtual screening. , 2004, Journal of medicinal chemistry.

[67]  Maria Cristina Gamberini,et al.  Discovery of new inhibitors of aldose reductase from molecular docking and database screening. , 2002, Bioorganic & medicinal chemistry.

[68]  Somesh D. Sharma,et al.  Managing protein flexibility in docking and its applications. , 2009, Drug discovery today.

[69]  Catherine L. Worth,et al.  Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.

[70]  A. Plückthun,et al.  Antigen recognition by conformational selection , 1999, FEBS letters.

[71]  W Pangborn,et al.  Ligand-induced conformational changes in the crystal structures of Pneumocystis carinii dihydrofolate reductase complexes with folate and NADP+. , 2000, Biochemistry.

[72]  Holger Gohlke,et al.  Target flexibility: an emerging consideration in drug discovery and design. , 2008, Journal of medicinal chemistry.

[73]  C. K. Chu,et al.  Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents. , 2007, Biochemical pharmacology.

[74]  Christopher R. Corbeil,et al.  Docking Ligands into Flexible and Solvated Macromolecules, 1. Development and Validation of FITTED 1.0 , 2007, J. Chem. Inf. Model..

[75]  W. L. Jorgensen.  The Many Roles of Computation in Drug Discovery , 2004, Science.

[76]  P J Goodford,et al.  COMPOUNDS DESIGNED TO FIT A SITE OF KNOWN STRUCTURE IN HUMAN HAEMOGLOBIN , 1976, British journal of pharmacology.

[77]  S. Teague.  Implications of protein flexibility for drug discovery , 2003, Nature Reviews Drug Discovery.

[78]  I. Bahar,et al.  Structural changes involved in protein binding correlate with intrinsic motions of proteins in the unbound state. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[79]  G. Klebe,et al.  Ligand-supported homology modelling of protein binding-sites using knowledge-based potentials. , 2003, Journal of molecular biology.

[80]  X. Barril,et al.  Incorporating protein flexibility into docking and structure-based drug design , 2006, Expert opinion on drug discovery.

[81]  Athanasios Papakyriakou,et al.  Discovery of Potent Vascular Endothelial Growth Factor Receptor‐2 Inhibitors , 2010, ChemMedChem.